HomeLYRA • NASDAQ
Follow
Lyra Therapeutics Inc
Previous close
$0.29
Day range
$0.28 - $0.28
Year range
$0.25 - $6.79
Market cap
18.34M USD
Avg Volume
1.58M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 532.00K | 29.76% |
Operating expense | 5.82M | 13.48% |
Net income | -22.45M | -38.12% |
Net profit margin | -4.22K | -6.45% |
Earnings per share | -0.35 | 20.45% |
EBITDA | -23.39M | -37.34% |
Effective tax rate | -0.06% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 87.12M | 5.33% |
Total assets | 141.53M | 50.77% |
Total liabilities | 64.02M | 130.49% |
Total equity | 77.50M | — |
Shares outstanding | 60.96M | — |
Price to book | 0.23 | — |
Return on assets | -41.40% | — |
Return on capital | -50.77% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -22.45M | -38.12% |
Cash from operations | -22.46M | -41.67% |
Cash from investing | 7.86M | 47.83% |
Cash from financing | 8.64M | 216,000.00% |
Net change in cash | -5.95M | 43.46% |
Free cash flow | -14.75M | -67.74% |
About
Founded
2005
Headquarters
Website
Employees
109